CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Revenues	$ 6,443,065	$ 8,636,271	$ 17,019,538	$ 15,893,561
Cost of revenues	3,138,350	3,598,038	7,993,870	7,080,174
Gross profit	3,304,715	5,038,233	9,025,668	8,813,387
Operating expenses
Selling, general and administrative	3,401,501	3,012,972	7,228,825	5,717,921
Loss on abandonment of assets	42,898	0	42,898	0
Depreciation and amortization	506,477	395,510	1,008,854	729,271
Total operating expenses	3,950,876	3,408,482	8,280,576	6,447,192
Income (loss) from operations	(646,161)	1,629,751	745,092	2,366,195
Other income (expense)
Interest income	3,130	131,812	65,291	250,985
Total other income	3,130	131,812	65,291	250,985
Income (loss) before income tax provision (benefit) and noncontrolling interest	(643,031)	1,761,563	810,383	2,617,180
Income tax provision (benefit)	(423,797)	23,276	(511,348)	7,786
Net income (loss) before noncontrolling interest	(219,234)	1,738,287	1,321,731	2,609,394
Net loss attributable to the noncontrolling interest	0	504	0	1,068
Net income (loss) attributable to Paysign, Inc.	$ (219,234)	$ 1,738,791	$ 1,321,731	$ 2,610,462
Net income (loss) per share - basic	$ 0.00	$ 0.04	$ 0.03	$ 0.06
Net income (loss) per share - diluted	$ 0.00	$ 0.03	$ 0.02	$ 0.05
Weighted average common shares outstanding - basic	49,015,686	47,310,209	48,864,424	47,136,608
Weighted average common shares outstanding - diluted	54,396,850	54,967,595	54,542,458	54,739,483
Plasma Industry [Member]
Revenues	$ 4,572,439	$ 6,542,655	$ 11,915,849	$ 12,427,232
Pharma industry [Member]
Revenues	1,768,565	2,093,616	4,788,942	3,466,329
Other [Member]
Revenues	$ 102,061	$ 0	$ 314,747	$ 0